封面
市場調查報告書
商品編碼
1622903

全球腹膜透析市場:按治療類型、按產品類型、按最終用戶、按地區、範圍和預測

Global Peritoneal Dialysis Market By Treatment Type (Continuous Ambulatory Peritoneal Dialysis, Automated Peritoneal Dialysis ), By Product Type, By End User, By Geographic Scope and Forecast

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球腹膜透析市場規模及預測

2024年全球腹膜透析市場規模估值為854.1億美元,預計2024年至2031年複合年增長率為7.30%,預計2031年達到1500.8億美元。腹膜透析是一種腎臟替代療法,利用腹膜(覆蓋腹腔的膜)作為天然過濾器來去除血液中的廢物和多餘的水分。在這種方法中,將無菌透析液注入腹膜腔,使廢物經由腹膜吸收,然後排出。

腹膜透析廣泛用於慢性腎臟病或等待腎臟移植的患者,具有居家治療、改善生活品質和生活方式靈活性等優點。

腹膜透析的未來充滿希望,技術和解決方案的進步旨在改善患者的治療效果、提高液體和溶質清除的效率並減少併發症。

全球腹膜透析市場動態

塑造全球腹膜透析市場的主要市場動態

主要市場推動因素

慢性腎臟病 (CKD) 盛行率上升:

慢性腎臟病(CKD)盛行率上升:慢性腎臟病患者病率上升是透析治療需求的主要驅動力。根據美國疾病管制與預防中心 (CDC) 的數據,估計美國約有 3,700 萬成年人患有 CKD,其中很大一部分需要透析。

老化進展:

人口老化是腹膜透析市場擴大的關鍵因素。世界衛生組織 (WHO) 預測,到 2050 年,全球 60 歲及以上人口將達到 20 億,預計將增加腎臟相關疾病的盛行率和透析選擇的需求。

轉向居家照護:

居家透析已成為一種值得注意的趨勢,因為它為患者提供了便利性和自主性。美國腎臟數據系統 (USRDS) 報告稱,截至 2020 年,美國約 8% 的透析患者使用腹膜透析,這反映出人們越來越傾向於居家治療。

技術進步:

腹膜透析設備和解決方案的創新正在提高治療效率和患者治療效果。根據國際腹膜透析協會的報告,新的自動化系統和改進的透析解決方案有可能提高患者的接受度和滿意度並推動市場成長。2022年腹膜透析市場規模預估為45億美元,至2030年複合年增長率(CAGR)為6.5%。

主要課題

感染風險:腹膜透析具有很高的感染風險,尤其是腹膜炎,這使得治療變得複雜並可能導致嚴重的健康問題。這些風險可能會阻止患者選擇腹膜透析而不是血液透析。

病患教育與訓練:有效實施腹膜透析需要適當的病患教育和培訓,以實現成功的家庭治療。許多患者可能缺乏獲得必要技能所需的支持和資源,這可能會影響依從性和治療結果。

取得和負擔能力:在某些地區,特別是在低收入和農村地區,獲得腹膜透析的機會可能受到限制。此外,與設備、用品和醫療保健服務相關的高成本可能成為尋求這種治療的患者的障礙。

心理社會因素:焦慮、憂鬱和社會孤立等心理因素會影響患者接受居家透析的意願。解決這些社會心理課題對於提高治療依從性和生活品質至關重要。

主要趨勢

數位醫療技術的整合:遠距醫療和遠端監控技術的引入正在加強腹膜透析的患者管理和後續護理。這些創新透過提高對治療方案的依從性並允許及時幹預來改善患者的治療結果。

個人化治療方法:在腹膜透析中,個人化醫療的趨勢日益增長,即根據每位患者的需求量身訂做治療計畫。這包括根據患者特定參數調整透析液和時間表,從而提高療效和滿意度。

擴大病患教育計畫:針對病患和醫療保健提供者的強化教育計畫變得越來越普遍。此類計劃的重點是對患者進行有關腹膜透析程序、潛在併發症和管理策略的教育,從而提高依從性和治療結果。

加強研究和開發:繼續研究改良腹膜透析液和機器是當務之急。該公司正在投資開發新型生物相容性腹膜透析液和自動化系統,以提高腹膜透析的效率和安全性,並有望在未來幾年上市的產品。

目錄

第1章 全球腹膜透析市場簡介

  • 市場概況
  • 調查範圍
  • 先決條件

第 2 章執行摘要

第3章 驗證市場研究研究方法

  • 數據挖掘
  • 驗證
  • 一次資料
  • 數據源列表

第4章 全球腹膜透析市場展望

  • 概述
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 波特的五力模型
  • 價值鏈分析

第5章全球腹膜透析市場:依治療類型

  • 概述
  • 連續性門診腹膜透析(CAPD)
  • 自動腹膜透析(APD)

第6章全球腹膜透析市場:依產品類型

  • 概述
  • 腹膜透析液
  • 腹膜透析裝置
  • 腹膜透析儀
  • 導管
  • 其他

第7章全球腹膜透析市場:依最終使用者分類

  • 概述
  • 家庭透析
  • 透析中心及醫院透析

第8章全球腹膜透析市場:按地區

  • 概述
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 亞太其他地區
  • 世界其他地區
    • 拉丁美洲
    • 中東/非洲

第9章 全球腹膜透析市場競爭狀況

  • 概述
  • 各公司市場排名
  • 主要發展策略

第10章 公司簡介

  • Baxter International Inc.
  • Fresenius Medical Care
  • NxStage Medical Inc.
  • DaVita Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Nipro Corporation
  • B. Braun Melsungen AG
  • Minntech Corporation
  • Maruho Co., Ltd.
  • Terumo Corporation

第11章 主要進展

  • 產品發佈/開發
  • 併購
  • 業務拓展
  • 夥伴關係和聯盟

第12章附錄

  • 相關研究
簡介目錄
Product Code: 5350

Global Peritoneal Dialysis Market Size and Forecast

Global Peritoneal Dialysis Market size was valued at USD 85.41 Billion in 2024 and is projected to reach USD 150.08 Billion by 2031 , growing at a CAGR of 7.30% from 2024 to 2031. Peritoneal Dialysis is a renal replacement therapy that utilizes the peritoneum, a membrane lining the abdominal cavity, as a natural filter to remove waste products and excess fluids from the bloodstream. This method involves the infusion of a sterile dialysis solution into the abdominal cavity, where it absorbs waste through the peritoneal membrane and is then drained out.

Widely used for patients with chronic kidney disease or those awaiting kidney transplantation, peritoneal dialysis offers the advantages of home-based treatment, improved quality of life, and flexibility in lifestyle.

The future of peritoneal dialysis looks promising, with advancements in technology and solutions aimed at enhancing patient outcomes, increasing the efficiency of fluid and solute removal, and reducing complications.

Global Peritoneal Dialysis Market Dynamics

The key market dynamics that are shaping the global peritoneal dialysis market include:

Key Market Drivers:

Rising Prevalence of Chronic Kidney Disease (CKD):

The increasing incidence of chronic kidney disease significantly drives the demand for dialysis treatments. According to the Centers for Disease Control and Prevention (CDC), approximately 37 million adults in the United States are estimated to have CKD, with a significant proportion requiring dialysis.

Growing Aging Population:

The aging population is a critical factor in the expansion of the peritoneal dialysis market. The World Health Organization (WHO) projects that the global population aged 60 years and older will reach 2 billion by 2050, which is expected to increase the prevalence of kidney-related diseases and the need for dialysis options.

Shift Toward Home-Based Care:

There is a notable trend toward home-based dialysis solutions due to the convenience and autonomy they offer patients. According to a report from the United States Renal Data System (USRDS), as of 2020, approximately 8% of all dialysis patients in the U.S. were using peritoneal dialysis, reflecting a growing preference for home therapies.

Technological Advancements:

Innovations in peritoneal dialysis equipment and solutions are enhancing treatment efficiency and patient outcomes. The International Society for Peritoneal Dialysis reported that new automated systems and improved dialysis solutions have the potential to increase patient acceptance and satisfaction, driving market growth. In 2022, the peritoneal dialysis market was valued at $4.5 billion and is projected to grow at a compound annual growth rate (CAGR) of 6.5% through 2030.

Key Challenges:

Infection Risks: Peritoneal dialysis is associated with a higher risk of infections, particularly peritonitis, which can complicate treatment and lead to severe health issues. This risk can deter patients from choosing this modality over hemodialysis.

Patient Education and Training: Effective peritoneal dialysis requires proper patient education and training to ensure successful home-based treatment. Many patients may lack the necessary support or resources to learn the required techniques, which can affect compliance and outcomes.

Access and Affordability: Access to peritoneal dialysis can be limited in certain regions, particularly in low-income or rural areas. Additionally, high costs associated with equipment, supplies, and healthcare services can pose a barrier for patients seeking this treatment.

Psychosocial Factors: Psychological aspects such as anxiety, depression, and social isolation can impact patients' willingness to engage in home dialysis. Addressing these psychosocial challenges is essential for improving treatment adherence and quality of life.

Key Trends:

Integration of Digital Health Technologies: The incorporation of telehealth and remote monitoring technologies is enhancing patient management and follow-up care in peritoneal dialysis. These innovations allow for better adherence to treatment protocols and timely intervention, thereby improving patient outcomes.

Personalized Treatment Approaches: There is a growing trend toward personalized medicine in peritoneal dialysis, where treatment plans are tailored to individual patient needs. This includes adjusting dialysis solutions and schedules based on patient-specific parameters, which can improve efficacy and satisfaction.

Expansion of Patient Education Programs: Enhanced educational initiatives aimed at both patients and healthcare providers are becoming more common. These programs focus on training patients about peritoneal dialysis procedures, potential complications, and management strategies, leading to better compliance and outcomes.

Increased Research and Development: Ongoing research efforts to improve peritoneal dialysis solutions and equipment are being prioritized. Companies are investing in developing new biocompatible solutions and automated systems to enhance the efficiency and safety of peritoneal dialysis, with several promising products expected to enter the market in the coming years.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Peritoneal Dialysis Market Regional Analysis

Here is a more detailed regional analysis of the global peritoneal dialysis market:

North America:

North America is the dominant region in the global peritoneal dialysis market, accounting for a significant share due to advanced healthcare infrastructure and a well-established reimbursement framework. According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 37 million adults in the United States are estimated to have CKD, with a substantial proportion requiring dialysis treatment, driving the demand for peritoneal dialysis.

The presence of key market players, such as Baxter International and Fresenius Medical Care, further strengthens North America's leading position in the peritoneal dialysis market. In 2023, the North American market for peritoneal dialysis was valued at approximately $1.2 billion, reflecting a robust growth trajectory fueled by technological advancements and increased patient education regarding home-based treatment options.

Asia Pacific:

The Asia Pacific region is the fastest-growing market for peritoneal dialysis, driven by rapid urbanization, increasing healthcare awareness, and a rising prevalence of kidney diseases. According to the National Kidney Foundation, the prevalence of kidney disease in India is expected to reach 200 million by 2030, highlighting the urgent need for effective treatment solutions.

Technological advancements and collaborations between healthcare providers and manufacturers also fuel market growth in the Asia Pacific region. In 2023, the Asia Pacific peritoneal dialysis market was valued at approximately $600 million, and it is projected to grow at a compound annual growth rate (CAGR) of over 10% through the next five years.

Global Peritoneal Dialysis Market: Segmentation Analysis

The Global Peritoneal Dialysis Market is segmented on the basis of By Treatment Type, By Product Type, By End User, and By Geography.

Global Peritoneal Dialysis Market, By Treatment Type

  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

Based on Treatment Type, the Global Peritoneal Dialysis Market is segmented into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). Continuous Ambulatory Peritoneal Dialysis (CAPD) is the dominating segment due to its simplicity and the ability for patients to manage their treatments independently without the need for machines. However, Automated Peritoneal Dialysis (APD) is the fastest-growing segment, driven by advancements in technology and the increasing demand for more convenient and efficient treatment options.

Global Peritoneal Dialysis Market, By Product Type

  • Peritoneal Dialysis Solution Device
  • Peritoneal Dialysis Set
  • Catheter

Based on Product Type, the Global Peritoneal Dialysis Market is segmented into Peritoneal Dialysis Solution Device, Peritoneal Dialysis Set and Catheter. The Peritoneal Dialysis Solution Device is the dominating segment due to its essential role in the dialysis process and the high demand for effective dialysis solutions. However, the Peritoneal Dialysis Set segment is the fastest-growing, driven by increasing adoption rates of home-based dialysis and advancements in technology that enhance user convenience and treatment efficacy.

Global Peritoneal Dialysis Market, By End User

  • Home-based Dialysis
  • Dialysis Center & Hospital-based Dialysis

Based on End User, the Global Peritoneal Dialysis Market is segmented into Home-based Dialysis and Dialysis Center & Hospital-based Dialysis. Home-based dialysis is the dominating segment due to its convenience and patient autonomy, allowing individuals to manage their treatment in the comfort of their homes. However, the fastest-growing segment is hospital-based dialysis, driven by advancements in technology, improved treatment options, and increasing awareness among healthcare providers about the benefits of in-center treatment for patients with complex medical needs.

Global Peritoneal Dialysis Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on the Geography, the Global Peritoneal Dialysis Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America is the dominant region in the global peritoneal dialysis market, accounting for a significant share due to advanced healthcare infrastructure and a well-established reimbursement framework. The Asia Pacific region is the fastest-growing market for peritoneal dialysis, driven by rapid urbanization, increasing healthcare awareness, and a rising prevalence of kidney diseases.

Key Players

  • The "Global Peritoneal Dialysis Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market
  • Fresenius Medical Care, Baxter International Inc., NxStage Medical Inc., DaVita Inc., Asahi Kasei Medical Co., Ltd., Nipro Corporation, Braun Melsungen AG, Minntech Corporation, Maruho Co., Ltd., Terumo Corporation, Fresenius Kabi, Bellco Medical LLC, Vascular Solutions, Inc., Medtronic plc, Quanta Dialysis Technologies Ltd., Dialysis Clinic, Inc., US Renal Care, FMC Corporation, Amicus Therapeutics, Inc.
  • Our
  • market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
  • Global Peritoneal Dialysis Market: Recent Developments
  • In August 2024 Baxter International revealed plans to expand its manufacturing facilities for peritoneal dialysis products in response to increasing global demand. The expansion will enhance the company's production capacity and improve supply chain efficiency, allowing for quicker distribution of their innovative dialysis solutions.
  • In July 2024 Medtronic announced a collaboration with several digital health companies to integrate remote monitoring capabilities into its peritoneal dialysis devices. This partnership aims to enhance patient engagement and streamline treatment management through real-time data sharing between patients and healthcare providers.
  • In June 2024 Terumo Corporation unveiled new research initiatives focused on developing advanced peritoneal dialysis products that utilize biocompatible materials.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PERITONEAL DIALYSIS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL PERITONEAL DIALYSIS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL PERITONEAL DIALYSIS MARKET, BY TREATMENT TYPE

  • 5.1 Overview
  • 5.2 Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • 5.3 Automated Peritoneal Dialysis (APD)

6 GLOBAL PERITONEAL DIALYSIS MARKET, BY PRODUCT TYPE

  • 6.1 Overview
  • 6.2 Peritoneal Dialysis Solution
  • 6.3 Device
  • 6.4 Peritoneal Dialysis Set
  • 6.5 Catheter
  • 6.6 Others

7 GLOBAL PERITONEAL DIALYSIS MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Home-based Dialysis
  • 7.3 Dialysis Center & Hospital-based Dialysis

8 GLOBAL PERITONEAL DIALYSIS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL PERITONEAL DIALYSIS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Baxter International Inc.
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Fresenius Medical Care
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 NxStage Medical Inc.
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 DaVita Inc.
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Asahi Kasei Medical Co., Ltd.
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Nipro Corporation
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 B. Braun Melsungen AG
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Minntech Corporation
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Maruho Co., Ltd.
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Terumo Corporation
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research